Creo Medical Group Plc (CREO) Ord GBP0.001
Sell:16.50pBuy:16.75p
0.50p
(3.10%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:16.50p
Buy:16.75p
Change:0.50p
(3.10%)
0.50p
(3.10%)Prices delayed by at least 15 minutes
Sell:16.50p
Buy:16.75p
Change:0.50p
(3.10%)
0.50p
(3.10%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 76,740 | £0.20 | £15,355.67 | 3,036,540 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 98,000 | £0.20 | £19,609.80 | 2,959,800 |
| 24 October 2024 | Richard John ReesCFO | Sell Regular sell transaction (market) | 174,740 | £0.20 | £34,948.00 | 2,861,800 |
| 31 July 2024 | Christopher Paul (Chris) HancockCTO | Buy Regular purchase transaction | 2,748 | £0.33 | £899.97 | 4,819,161 |
| 31 July 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 2,748 | £0.33 | £899.97 | 2,822,711 |
| 16 July 2024 | Craig Jonathan GullifordCEO | Buy Regular purchase transaction | 2,748 | £0.33 | £899.97 | 1,652,771 |
| 19 January 2024 | Christopher Paul (Chris) HancockCTO | Buy Regular purchase transaction | 2,069 | £0.44 | £900.02 | 4,812,275 |
| 19 January 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 2,069 | £0.44 | £900.02 | 2,815,825 |
| 19 January 2024 | Craig Jonathan GullifordCEO | Buy Regular purchase transaction | 2,069 | £0.44 | £900.02 | 1,640,389 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 October 2024 | Richard John ReesCFO | Sell Regular sell transaction (market) | 174,740 | £0.20 | £34,948.00 | 2,861,800 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 98,000 | £0.20 | £19,609.80 | 2,959,800 |
| 24 October 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 76,740 | £0.20 | £15,355.67 | 3,036,540 |
| 19 January 2024 | Christopher Paul (Chris) HancockCTO | Buy Regular purchase transaction | 2,069 | £0.44 | £900.02 | 4,812,275 |
| 19 January 2024 | Richard John ReesCFO | Buy Regular purchase transaction | 2,069 | £0.44 | £900.02 | 2,815,825 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.